Literature DB >> 18931689

FLIP and the death effector domain family.

J W Yu1, Y Shi.   

Abstract

Death effector domains (DEDs) are protein interaction modules found in a number of proteins known to regulate apoptosis from death receptors. The core DED family members that orchestrate programmed cell death from death receptors include the adaptor protein FADD, the initiator caspases procaspases-8 and -10 and the regulatory protein c-FLIP. Through homotypic DED interactions, these proteins assemble into the death-inducing signaling complex (DISC) to regulate initiator caspase activation and launch the apoptotic proteolytic cascade. A considerable body of evidence, however, is revealing that the same core group of DED-containing proteins also paradoxically promotes survival and proliferation in lymphocytes and possibly other cell types. This review delves into recent findings regarding these two opposing functional aspects of the core DED proteins. We discuss the current effort expanding our structural and biochemical view of how DED proteins assemble into the DISC to fully activate initiator caspases and execute cell death, and finally we examine details linking the same proteins to proliferation and describe how this outcome might be achieved through restricted activation of initiator caspases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931689     DOI: 10.1038/onc.2008.299

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  67 in total

1.  Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes.

Authors:  Paul Eggleton; Lorna W Harries; Giada Alberigo; Paul Wordsworth; Nick Viner; Richard Haigh; Suzanne Donnelly; Hugh W Jones; Ian C Chikanza; Thomas W E O'Conner; Alasdair E R Thomson; Paul G Winyard
Journal:  J Clin Immunol       Date:  2010-06-09       Impact factor: 8.317

2.  FLIP: a novel regulator of macrophage differentiation and granulocyte homeostasis.

Authors:  Qi-Quan Huang; Harris Perlman; Zan Huang; Robert Birkett; Lixin Kan; Hemant Agrawal; Alexander Misharin; Sandeep Gurbuxani; John D Crispino; Richard M Pope
Journal:  Blood       Date:  2010-08-19       Impact factor: 22.113

Review 3.  Photoreceptor cell death and rescue in retinal detachment and degenerations.

Authors:  Yusuke Murakami; Shoji Notomi; Toshio Hisatomi; Toru Nakazawa; Tatsuro Ishibashi; Joan W Miller; Demetrios G Vavvas
Journal:  Prog Retin Eye Res       Date:  2013-08-28       Impact factor: 21.198

4.  Cancer-associated missense mutations of caspase-8 activate nuclear factor-κB signaling.

Authors:  Mizuo Ando; Masahito Kawazu; Toshihide Ueno; Kazutaka Fukumura; Azusa Yamato; Manabu Soda; Yoshihiro Yamashita; Young L Choi; Tatsuya Yamasoba; Hiroyuki Mano
Journal:  Cancer Sci       Date:  2013-06-07       Impact factor: 6.716

5.  Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy.

Authors:  Xue Wei Meng; Michael P Heldebrant; Karen S Flatten; David A Loegering; Haiming Dai; Paula A Schneider; Timothy S Gomez; Kevin L Peterson; Sergey A Trushin; Allan D Hess; B Douglas Smith; Judith E Karp; Daniel D Billadeau; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

6.  Molluscum Contagiosum Virus MC159 Abrogates cIAP1-NEMO Interactions and Inhibits NEMO Polyubiquitination.

Authors:  Sunetra Biswas; Joanna L Shisler
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

7.  Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL.

Authors:  Nicolai Fricker; Joel Beaudouin; Petra Richter; Roland Eils; Peter H Krammer; Inna N Lavrik
Journal:  J Cell Biol       Date:  2010-08-09       Impact factor: 10.539

8.  c-Flip overexpression affects satellite cell proliferation and promotes skeletal muscle aging.

Authors:  C Giampietri; S Petrungaro; P Coluccia; F Antonangeli; K Giannakakis; T Faraggiana; A Filippini; G Cossu; E Ziparo
Journal:  Cell Death Dis       Date:  2010-04-29       Impact factor: 8.469

9.  Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer.

Authors:  T Trarbach; M Moehler; V Heinemann; C-H Köhne; M Przyborek; C Schulz; V Sneller; G Gallant; S Kanzler
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640

10.  Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment.

Authors:  Peter Geserick; Mike Hupe; Maryline Moulin; W Wei-Lynn Wong; Maria Feoktistova; Beate Kellert; Harald Gollnick; John Silke; Martin Leverkus
Journal:  J Cell Biol       Date:  2009-12-28       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.